178 related articles for article (PubMed ID: 12110539)
41. Fat distribution and metabolic changes are strongly correlated and energy expenditure is increased in the HIV lipodystrophy syndrome.
Kosmiski LA; Kuritzkes DR; Lichtenstein KA; Glueck DH; Gourley PJ; Stamm ER; Scherzinger AL; Eckel RH
AIDS; 2001 Oct; 15(15):1993-2000. PubMed ID: 11600828
[TBL] [Abstract][Full Text] [Related]
42. Highly active antiretroviral therapy-induced lipodystrophy has minor effects on human immunodeficiency virus-induced changes in lipolysis, but normalizes resting energy expenditure.
van der Valk M; Reiss P; van Leth FC; Ackermans MT; Endert E; Romijn JA; Heijligenberg R; Sauerwein H
J Clin Endocrinol Metab; 2002 Nov; 87(11):5066-71. PubMed ID: 12414873
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of lipolysis improves insulin sensitivity in protease inhibitor-treated HIV-infected men with fat redistribution.
Hadigan C; Rabe J; Meininger G; Aliabadi N; Breu J; Grinspoon S
Am J Clin Nutr; 2003 Feb; 77(2):490-4. PubMed ID: 12540412
[TBL] [Abstract][Full Text] [Related]
44. In vivo evidence of impaired peripheral fatty acid trapping in patients with human immunodeficiency virus-associated lipodystrophy.
van Wijk JP; Cabezas MC; de Koning EJ; Rabelink TJ; van der Geest R; Hoepelman IM
J Clin Endocrinol Metab; 2005 Jun; 90(6):3575-82. PubMed ID: 15784707
[TBL] [Abstract][Full Text] [Related]
45. Extending food deprivation reverses the short-term lipolytic response to fasting: role of the triacylglycerol/fatty acid cycle.
Weber JM; Reidy SP
J Exp Biol; 2012 May; 215(Pt 9):1484-90. PubMed ID: 22496284
[TBL] [Abstract][Full Text] [Related]
46. Lipolysis and lipid oxidation in weight-losing cancer patients and healthy subjects.
Zuijdgeest-van Leeuwen SD; van den Berg JW; Wattimena JL; van der Gaast A; Swart GR; Wilson JH; Dagnelie PC
Metabolism; 2000 Jul; 49(7):931-6. PubMed ID: 10910006
[TBL] [Abstract][Full Text] [Related]
47. Severely dysregulated disposal of postprandial triacylglycerols exacerbates hypertriacylglycerolemia in HIV lipodystrophy syndrome.
Sekhar RV; Jahoor F; Pownall HJ; Rehman K; Gaubatz J; Iyer D; Balasubramanyam A
Am J Clin Nutr; 2005 Jun; 81(6):1405-10. PubMed ID: 15941894
[TBL] [Abstract][Full Text] [Related]
48. Markedly diminished lipolysis and partial restoration of glucose metabolism, without changes in fat distribution after extended discontinuation of protease inhibitors in severe lipodystrophic human immunodeficient virus-1-infected patients.
van der Valk M; Allick G; Weverling GJ; Romijn JA; Ackermans MT; Lange JM; van Eck-Smit BL; van Kuijk C; Endert E; Sauerwein HP; Reiss P
J Clin Endocrinol Metab; 2004 Jul; 89(7):3554-60. PubMed ID: 15240645
[TBL] [Abstract][Full Text] [Related]
49. Leptin replacement therapy does not improve the abnormal lipid kinetics of hypoleptinemic patients with HIV-associated lipodystrophy syndrome.
Sekhar RV; Jahoor F; Iyer D; Guthikonda A; Paranilam J; Elhaj F; Coraza I; Balasubramanyam A
Metabolism; 2012 Oct; 61(10):1395-403. PubMed ID: 22542724
[TBL] [Abstract][Full Text] [Related]
50. Energy expenditure and adaptive responses to an acute hypercaloric fat load in humans with lipodystrophy.
Savage DB; Murgatroyd PR; Chatterjee VK; O'Rahilly S
J Clin Endocrinol Metab; 2005 Mar; 90(3):1446-52. PubMed ID: 15613417
[TBL] [Abstract][Full Text] [Related]
51. Alterations in lipid kinetics in men with HIV-dyslipidemia.
Reeds DN; Mittendorfer B; Patterson BW; Powderly WG; Yarasheski KE; Klein S
Am J Physiol Endocrinol Metab; 2003 Sep; 285(3):E490-7. PubMed ID: 12746213
[TBL] [Abstract][Full Text] [Related]
52. Lipolysis and lipid oxidation in cirrhosis and after liver transplantation.
Shangraw RE; Jahoor F
Am J Physiol Gastrointest Liver Physiol; 2000 Jun; 278(6):G967-73. PubMed ID: 10859227
[TBL] [Abstract][Full Text] [Related]
53. The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia.
Mulligan K; Khatami H; Schwarz JM; Sakkas GK; DePaoli AM; Tai VW; Wen MJ; Lee GA; Grunfeld C; Schambelan M
J Clin Endocrinol Metab; 2009 Apr; 94(4):1137-44. PubMed ID: 19174500
[TBL] [Abstract][Full Text] [Related]
54. Reduction of abdominal obesity in lipodystrophy associated with human immunodeficiency virus infection by means of diet and exercise: case report and proof of principle.
Roubenoff R; Schmitz H; Bairos L; Layne J; Potts E; Cloutier GJ; Denry F
Clin Infect Dis; 2002 Feb; 34(3):390-3. PubMed ID: 11774087
[TBL] [Abstract][Full Text] [Related]
55. Fatty acid cycling in the fasting rat.
Kalderon B; Mayorek N; Berry E; Zevit N; Bar-Tana J
Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E221-7. PubMed ID: 10893343
[TBL] [Abstract][Full Text] [Related]
56. Release, oxidation, and reesterification of fatty acids from infused triglycerides: effect of heparin.
Chen X; Ruiz J; Boden G
Metabolism; 1995 Dec; 44(12):1590-5. PubMed ID: 8786729
[TBL] [Abstract][Full Text] [Related]
57. Gender differences in lipid and glucose kinetics during short-term fasting.
Mittendorfer B; Horowitz JF; Klein S
Am J Physiol Endocrinol Metab; 2001 Dec; 281(6):E1333-9. PubMed ID: 11701450
[TBL] [Abstract][Full Text] [Related]
58. Whole body lipid and energy metabolism in the cancer patient.
Legaspi A; Jeevanandam M; Starnes HF; Brennan MF
Metabolism; 1987 Oct; 36(10):958-63. PubMed ID: 3657515
[TBL] [Abstract][Full Text] [Related]
59. The association of lipodystrophy and oxidative stress biomarkers in HIV-infected men.
Vassimon HS; Deminice R; Machado AA; Monteiro JP; Jordao AA
Curr HIV Res; 2010 Jul; 8(5):364-9. PubMed ID: 20353389
[TBL] [Abstract][Full Text] [Related]
60. Age-Related Lipid Metabolic Signature in Human LMNA-Lipodystrophic Stem Cell-Derived Adipocytes.
Sánchez P; Infante A; de Eguino GR; Fuentes-Maestre JA; García-Verdugo JM; Rodríguez CI
J Clin Endocrinol Metab; 2015 Jul; 100(7):E964-73. PubMed ID: 25961135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
